<--- Back to Details
First PageDocument Content
Clinical pharmacology / Food and Drug Administration / Pharmacology / Therapeutics / United States Public Health Service / Generic drug / Riegel v. Medtronic /  Inc. / Product liability / Negligent infliction of emotional distress / Pharmaceutical sciences / Law / Clinical research
Date: 2011-10-31 16:15:21
Clinical pharmacology
Food and Drug Administration
Pharmacology
Therapeutics
United States Public Health Service
Generic drug
Riegel v. Medtronic
Inc.
Product liability
Negligent infliction of emotional distress
Pharmaceutical sciences
Law
Clinical research

IronHealth® GENERIC PHARMA LIABILITY AFTER THE U.S. SUPREME COURT’S MENSING RULING1 By: Kristin D. McMahon, Esq., Chief Claims Officer, IronHealth*

Add to Reading List

Source URL: www.ecinewsletter.com

Download Document from Source Website

File Size: 162,75 KB

Share Document on Facebook

Similar Documents

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

DocID: 1voig - View Document

Initiating Coverage  December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

DocID: 1vapl - View Document

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

DocID: 1v3IN - View Document

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

DocID: 1v3kf - View Document

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

DocID: 1v0Hj - View Document